Developing a Lipid-Based System for Co-delivery of a Vaccine and Adjuvants

University of British Columbia and Amgen British Columbia (ABC) will collaborate to develop a safe and efficient lipid-based vaccine delivery system that can be used in laboratory animals to enhance the production of specific antibodies against difficult targets. These antibodies can be further screened and characterized for treating various diseases in humans.

Intern: 
Mehrdad Bokharaei
Faculty Supervisor: 
Shyh-Dar Li
Province: 
British Columbia
Partner: 
Partner University: 
Program: